Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate 4 mg vs 5 mg in osteoporosis (BMD noninferiority)
TCTR20250724001Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of zoledronate in osteoporosis (2 arms), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
zoledronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on TCTR20250724001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250724001.